| Stage | NVDA | % of rev | ICHR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $96.2B | 100.00% | $295M | 100.00% | NVDA ×326.41 |
| Gross profit | $72.1B | 74.98% | $41M | 13.90% | NVDA +61.1pp |
| Operating income | $63.7B | 66.24% | $7M | 2.44% | NVDA +63.8pp |
| Pre-tax income | $71.5B | 74.32% | $5M | 1.84% | NVDA +72.5pp |
| Net income | $59.7B | 62.03% | $998,000 | 0.34% | NVDA +61.7pp |
| Stage | NVDA | ICHR | Gap · A − B |
|---|---|---|---|
| Revenue | $96.2B100.00% | $295M100.00% | NVDA ×326.41 |
| Gross profit | 74.98%$72.1B | 13.90%$41M | NVDA +61.1pp |
| Operating income | 66.24%$63.7B | 2.44%$7M | NVDA +63.8pp |
| Pre-tax income | 74.32%$71.5B | 1.84%$5M | NVDA +72.5pp |
| Net income |
| 62.03%$59.7B |
| 0.34%$998,000 |
| NVDA +61.7pp |
No shared counterparties.